These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23062310)

  • 41. Type 2 innate immune responses and the natural helper cell.
    Koyasu S; Moro K
    Immunology; 2011 Apr; 132(4):475-81. PubMed ID: 21323663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-33/ST2 axis in inflammation and immunopathology.
    Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
    Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor.
    Broekman W; Amatngalim GD; de Mooij-Eijk Y; Oostendorp J; Roelofs H; Taube C; Stolk J; Hiemstra PS
    Respir Res; 2016 Jan; 17():3. PubMed ID: 26753875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.
    Li L; Zhu H; Zuo X
    Front Immunol; 2018; 9():2663. PubMed ID: 30498500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal Ecological Network of Epithelium and Immune Cells for Gut Homeostasis and Tissue Healing.
    Kurashima Y; Kiyono H
    Annu Rev Immunol; 2017 Apr; 35():119-147. PubMed ID: 28125357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?
    Moussion C; Ortega N; Girard JP
    PLoS One; 2008 Oct; 3(10):e3331. PubMed ID: 18836528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut.
    Andoh A; Bamba S; Brittan M; Fujiyama Y; Wright NA
    Pharmacol Ther; 2007 Apr; 114(1):94-106. PubMed ID: 17328956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of interleukin-33 in organ fibrosis.
    Di Carmine S; Scott MM; McLean MH; McSorley HJ
    Discov Immunol; 2022; 1(1):kyac006. PubMed ID: 38566909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-33 in Rheumatic Diseases.
    Dong Y; Zhong J; Dong L
    Front Med (Lausanne); 2021; 8():739489. PubMed ID: 34589505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
    Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
    J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast/myofibroblast apoptosis in the regeneration/healing process from TNBS-induced colitis.
    Abe Y; Murano M; Murano N; Morita E; Inoue T; Kawakami K; Ishida K; Kuramoto T; Kakimoto K; Okada T; Narabayashi K; Umegaki E; Higuchi K
    Dig Dis Sci; 2012 Feb; 57(2):335-44. PubMed ID: 21909991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of interleukin-22 in inflammatory bowel disease.
    Li LJ; Gong C; Zhao MH; Feng BS
    World J Gastroenterol; 2014 Dec; 20(48):18177-88. PubMed ID: 25561785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-33 and Airway Inflammation.
    Oboki K; Nakae S; Matsumoto K; Saito H
    Allergy Asthma Immunol Res; 2011 Apr; 3(2):81-8. PubMed ID: 21461246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice.
    Oshio T; Komine M; Tsuda H; Tominaga SI; Saito H; Nakae S; Ohtsuki M
    J Dermatol Sci; 2017 Feb; 85(2):106-114. PubMed ID: 27839630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-33 is a crucial amplifier of innate rather than acquired immunity.
    Oboki K; Ohno T; Kajiwara N; Arae K; Morita H; Ishii A; Nambu A; Abe T; Kiyonari H; Matsumoto K; Sudo K; Okumura K; Saito H; Nakae S
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18581-6. PubMed ID: 20937871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-33, a potent inducer of adaptive immunity to intestinal nematodes.
    Humphreys NE; Xu D; Hepworth MR; Liew FY; Grencis RK
    J Immunol; 2008 Feb; 180(4):2443-9. PubMed ID: 18250453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving hard palate wound healing using immune modulatory autotherapies.
    Ballestas SA; Turner TC; Kamalakar A; Stephenson YC; Willett NJ; Goudy SL; Botchwey EA
    Acta Biomater; 2019 Jun; 91():209-219. PubMed ID: 31029828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation.
    Kjerrulf M; Grdic D; Kopf M; Lycke N
    Scand J Immunol; 1998 May; 47(5):401-7. PubMed ID: 9627122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.